UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 337

Sortiert nach

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells

Oncogene, 2014-08, Vol.33 (34), p.4359-4364

2014

Link zum Volltext

Verfügbarkeit prüfen

MEK5-ERK5 inhibitors target chronic myeloid leukemia stem cells and in combination with imatinib reduce the expression of stem cell genes

European journal of cancer (1990), 2016-07, Vol.61, p.S174-S174

2016

Link zum Volltext

Verfügbarkeit prüfen

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia

Cell death & disease, 2013-03, Vol.4 (3), p.e536-e536

2013

Link zum Volltext

Verfügbarkeit prüfen

ERK5 inhibition elicits cellular senescence in human melanoma cells

Journal of biological regulators and homeostatic agents, 2018-07, Vol.32 (4 Suppl. 1), p.44-44

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1 ETO-positive cells

Oncogene, 2008-03, Vol.27 (12), p.1767-1778

2008

Link zum Volltext

Verfügbarkeit prüfen

494: Prostaglandin E2 trans-activates the Colony-Stimulating Factor-1 (CSF-1) receptor and synergizes with CSF-1 in the induction of cell migration in macrophages via the mitogen-activated protein kinase ERK1/2

European journal of cancer (1990), 2014-07, Vol.50, p.S119-S119

2014

Link zum Volltext

Verfügbarkeit prüfen

Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells

Cell cycle (Georgetown, Tex.), 2015, Vol.14 (19), p.3146-3154

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of the protein kinase CK2 in the biology of cholangiocarcinoma cells

Digestive and liver disease, 2016-02, Vol.48, p.e20-e20

2016

Link zum Volltext

Verfügbarkeit prüfen

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia

Cell death & disease, 2013-03, Vol.4 (3), p.e536-e536

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors

Journal of biological regulators and homeostatic agents, 2018-07, Vol.32 (4 Suppl. 1), p.36-36

2018

Link zum Volltext

Verfügbarkeit prüfen

P94 c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO

Journal of hepatology, 2014-04, Vol.60 (1), p.S97-S98

2014

Link zum Volltext

Verfügbarkeit prüfen

TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation

The Journal of immunology (1950), 2001-02, Vol.166 (3), p.1583-1589

2001

Link zum Volltext

Verfügbarkeit prüfen

786: The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma

European journal of cancer (1990), 2014-07, Vol.50, p.S189-S189

2014

Link zum Volltext

Verfügbarkeit prüfen

1039 ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2013-04, Vol.58, p.S427-S427

2013

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the Extracellular Signal-Regulated Kinase ERK5 induces an increased expression of the Epidermal Growth Factor receptor and sensitizes hepatocarcinoma cells to gefitinib

Digestive and liver disease, 2023-09, Vol.55, p.S214

2023

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia suppresses BCR Abl and selects imatinib-insensitive progenitors within clonal CML populations

Leukemia, 2006-07, Vol.20 (7), p.1291-1293

2006

Link zum Volltext

Verfügbarkeit prüfen

Role of the interplay between ERK5 and hypoxia in intrahepatic cholangiocarcinoma cells

Digestive and liver disease, 2023-03, Vol.55, p.S49-S49

2023

Link zum Volltext

Verfügbarkeit prüfen

PO-099 Targeting the mitogen activated protein kinase ERK5 in human melanoma

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A59-A59

2018

Link zum Volltext

Verfügbarkeit prüfen

c-Rel and p27Kip are downstream targets of ERK5 in hepatocellular carcinoma (HCC) in vivo and in vitro

Digestive and liver disease, 2014-02, Vol.46, p.e37-e38

2014

Link zum Volltext

Verfügbarkeit prüfen

Positive correlation of HIF2α and SERPINB3 in human hepatocellular carcinoma: selectivity and prognostic implications

Digestive and liver disease, 2015-02, Vol.47, p.e41-e42

2015

Link zum Volltext

Verfügbarkeit prüfen

OC-04 Activation of the mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma

Digestive and liver disease, 2013-02, Vol.45, p.S2-S2

2013

Link zum Volltext

Verfügbarkeit prüfen

206 CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS

Journal of hepatology, 2011-03, Vol.54, p.S87-S87

2011

Link zum Volltext

Verfügbarkeit prüfen

892 ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS

Journal of hepatology, 2010, Vol.52, p.S347-S347

2010

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the cholangiocarcinoma stem-like compartment by monounsaturated fatty acids

Digestive and liver disease, 2022-03, Vol.54, p.S60-S61

2022

Link zum Volltext

Verfügbarkeit prüfen

Production and characterization of recombinant heteropolymers of human ferritin H and L chains

The Journal of biological chemistry, 1993-06, Vol.268 (17), p.12744-12748

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 337

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(281)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Humans
(93)
Life Sciences & Biomedicine
(82)
Biological And Medical Sciences
(39)
Female
(35)
Male
(32)
Animals
(29)
Medical Sciences
(26)
Adult
(25)
Middle Aged
(24)
Biochemistry & Molecular Biology
(23)
Physical Sciences
(23)
Fundamental And Applied Biological Sciences. Psychology
(21)
Aged
(18)
Infectious Diseases
(18)
Physics
(18)
Chemistry
(16)
Adolescent
(14)
Chemistry, Physical
(14)
Mice
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells

MEK5-ERK5 inhibitors target chronic myeloid leukemia stem cells and in combination with imatinib reduce the expression of stem cell genes

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia

ERK5 inhibition elicits cellular senescence in human melanoma cells

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1 ETO-positive cells

494: Prostaglandin E2 trans-activates the Colony-Stimulating Factor-1 (CSF-1) receptor and synergizes with CSF-1 in the induction of cell migration in macrophages via the mitogen-activated protein kinase ERK1/2

Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells

Role of the protein kinase CK2 in the biology of cholangiocarcinoma cells

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia

Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors

P94 c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO

TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation

786: The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma

1039 ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA

Inhibition of the Extracellular Signal-Regulated Kinase ERK5 induces an increased expression of the Epidermal Growth Factor receptor and sensitizes hepatocarcinoma cells to gefitinib

Hypoxia suppresses BCR Abl and selects imatinib-insensitive progenitors within clonal CML populations

Role of the interplay between ERK5 and hypoxia in intrahepatic cholangiocarcinoma cells

PO-099 Targeting the mitogen activated protein kinase ERK5 in human melanoma

c-Rel and p27Kip are downstream targets of ERK5 in hepatocellular carcinoma (HCC) in vivo and in vitro

Positive correlation of HIF2α and SERPINB3 in human hepatocellular carcinoma: selectivity and prognostic implications

OC-04 Activation of the mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma

206 CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS

892 ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS

Modulation of the cholangiocarcinoma stem-like compartment by monounsaturated fatty acids

Production and characterization of recombinant heteropolymers of human ferritin H and L chains

Suchergebnisse filtern